NCR3 and acute lymphoblastic leukemia: The expression of NKp30 (56.57%) and NKp46 (54.2%) on NK cells was elevated in ALL subjects at diagnosis as compared to healthy subjects (46.1% and 49.9%, respectively), which further reduced after induction chemotherapy (45.1% and 43.9%, respectively; Figure 5d,e).